{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:33:47Z","timestamp":1791146027388,"version":"4.1.0"},"reference-count":114,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T00:00:00Z","timestamp":1308009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Adult T cell leukemia\/lymphoma (ATL) represents an ideal model for targeted therapy because of intrinsic chemo-resistance of ATL cells and the presence of two well identified targets: the HTLV-I retrovirus and the viral oncoprotein Tax. The combination of zidovudine (AZT) and interferon-alpha (IFN) has a dramatic impact on survival of ATL patients. Although the mechanism of action remains unclear, arguments in favor or against a direct antiviral effect will be discussed. Yet, most patients relapse and alternative therapies are mandatory. IFN and arsenic trioxide induce Tax proteolysis, synergize to induce apoptosis in ATL cells and cure Tax-driven ATL in mice through specific targeting of leukemia initiating cell activity. These results provide a biological basis for the clinical success of arsenic\/IFN\/AZT therapy in ATL patients and suggest that both extinction of viral replication (AZT) and Tax degradation (arsenic\/IFN) are needed to cure ATL.<\/jats:p>","DOI":"10.3390\/v3060750","type":"journal-article","created":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T11:28:18Z","timestamp":1308137298000},"page":"750-769","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Controversies in Targeted Therapy of Adult T Cell Leukemia\/Lymphoma: ON Target or OFF Target Effects?"],"prefix":"10.3390","volume":"3","author":[{"given":"Rihab","family":"Nasr","sequence":"first","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba El","family":"Hajj","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youmna","family":"Kfoury","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues de","family":"Th\u00e9","sequence":"additional","affiliation":[{"name":"Service de Biochimie, Equipe labellis\u00e9e, Ligue Nationale Contre le Cancer, Centre National de la Recherche Scientifique, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Universit\u00e9 Paris Diderot Unit\u00e9 Mixte de Recherche 7212, Unit\u00e9 944, H\u00f4pital Saint Louis, 75475 Paris, Cedex 10, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"Service d\u2019h\u00e9matologie, Equipe labellis\u00e9e, Ligue Nationale Contre le Cancer, Centre National de la Recherche Scientifique, Universit\u00e9 Paris Descartes Unit\u00e9 Mixte de Recherche 8147, H\u00f4pital Necker-Enfants Malades, 75015 Paris, Cedex 15, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2011,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/sj.onc.1206551","article-title":"Human T-cell leukemia virus type I and adult T-cell leukemia","volume":"22","author":"Matsuoka","year":"2003","journal-title":"Oncogene"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/rmv.1980030304","article-title":"The epidemiology of human T-lymphotropic virus types I and II","volume":"3","author":"Kaplan","year":"1993","journal-title":"Rev. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/13550280390194028","article-title":"Human T-cell lymphotropic virus type I and neurological diseases","volume":"9","author":"Nagai","year":"2003","journal-title":"J. Neurovirol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/JCM.41.6.2593-2595.2003","article-title":"Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran","volume":"41","author":"Abbaszadegan","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.2910290606","article-title":"Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nation-wide sero-epidemiologic study","volume":"29","author":"Hinuma","year":"1982","journal-title":"Int. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.0141-9838.2004.00726.x","article-title":"Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis","volume":"26","author":"Carvalho","year":"2004","journal-title":"Parasite Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2741\/2163","article-title":"HTLV-1 Tax and adult T-cell leukemia","volume":"12","author":"Giam","year":"2007","journal-title":"Front. Biosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1349-7006.1989.tb02289.x","article-title":"Multi-step carcinogenesis model for adult T-cell leukemia","volume":"80","author":"Okamoto","year":"1989","journal-title":"Jpn. J. Canc. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","article-title":"Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease","volume":"81","author":"Yoshida","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood.V92.10.3557.422k09_3557_3561","article-title":"Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I","volume":"92","author":"Hisada","year":"1998","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00042560-199705010-00011","article-title":"Increased expression of interleukin-2 receptor alpha on peripheral blood mononuclear cells in HTLV-I tax\/rex mRNA-positive asymptomatic carriers","volume":"15","author":"Okayama","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.6089351","article-title":"Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II","volume":"226","author":"Slamon","year":"1984","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription","volume":"76","author":"Gaudray","year":"2002","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/v2092037","article-title":"Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis","volume":"2","author":"Kannian","year":"2010","journal-title":"Viruses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2217\/fmb.09.13","article-title":"HTLV gene regulation: because size matters, transcription is not enough","volume":"4","author":"Journo","year":"2009","journal-title":"Future Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0092-8674(03)00881-X","article-title":"The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV","volume":"115","author":"Manel","year":"2003","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1742-4690-7-99","article-title":"Current concepts regarding the HTLV-1 receptor complex","volume":"7","author":"Ghez","year":"2010","journal-title":"Retrovirology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1128\/JVI.02719-05","article-title":"Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry","volume":"80","author":"Ghez","year":"2006","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1128\/JVI.01522-06","article-title":"GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1","volume":"81","author":"Takenouchi","year":"2007","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1182\/blood-2008-04-150342","article-title":"HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165","volume":"113","author":"Lambert","year":"2009","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1172\/JCI27198","article-title":"HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death","volume":"116","author":"Sibon","year":"2006","journal-title":"J. Clin. Invest."},{"key":"ref_24","first-page":"7","article-title":"Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo","volume":"11","author":"Zane","year":"2010","journal-title":"Retrovirology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619","article-title":"Molecular mechanisms of human T-cell leukemia\/lymphotropic virus type I infection","volume":"86","author":"Franchini","year":"1995","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1038\/sj.onc.1206549","article-title":"Cellular Transformation by the HTLV-I Tax Protein, a Jack-of-All-Trades","volume":"22","author":"Gatza","year":"2003","journal-title":"Oncogene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.cdd.4401624","article-title":"Proapoptotic regimes for HTLV-I-transformed cells: Targeting Tax and the NF-kappaB pathway","volume":"12","author":"Kfoury","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_28","first-page":"7377","article-title":"Human T-cell leukemia virus type I Tax activation of NF-kappa B\/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene","volume":"14","author":"Sun","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1128\/jvi.70.5.2730-2735.1996","article-title":"Persistent activation of NF-kappa B\/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta","volume":"70","author":"Good","year":"1996","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0092-8674(00)81447-6","article-title":"HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation","volume":"93","author":"Yin","year":"1998","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"21132","DOI":"10.1074\/jbc.273.33.21132","article-title":"NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation","volume":"273","author":"Uhlik","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Journo, C., Filipe, J., About, F., Chevalier, S.A., Brady, J.N., Afonso, P.V., Flynn, D., Tangy, F., Isra\u00ebl, A., Vidalain, P.O., Weil, R., and Mahieux, R. (2009). NRP\/Optineurin Cooperates with TAX1BP1 to Potentiate the Activation of NF-\u03baB by Human T-Lymphotropic Virus Type 1 Tax Protein. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000521"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1093\/emboj\/20.23.6805","article-title":"Retroviral oncoprotein Tax induces processing of NF-kappaB2\/p100 in T cells: evidence for the involvement of IKKalpha","volume":"20","author":"Xiao","year":"2001","journal-title":"EMBO J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1073\/pnas.89.15.7070","article-title":"Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21 base-pair repeats by protein-protein interaction","volume":"89","author":"Zhao","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1073\/pnas.90.2.610","article-title":"The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1","volume":"90","author":"Suzuki","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1101\/gad.6.11.2066","article-title":"; Seiki, M: Interaction of HTLV-I Taxl with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes","volume":"6","author":"Fujii","year":"1992","journal-title":"Gene. Dev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1089\/08892220050193029","article-title":"Activation of oncogenic transcription factor AP-1 in T cells infected with the human T-cell leukemia virus type 1","volume":"16","author":"Fujii","year":"2000","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2010-05-285742","article-title":"Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome","volume":"117","author":"Kfoury","year":"2011","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/sj.onc.1210804","article-title":"Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome","volume":"27","author":"Kfoury","year":"2008","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2005-09-3572","article-title":"Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation","volume":"107","author":"Nasr","year":"2006","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1126\/science.2309119","article-title":"HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene","volume":"247","author":"Jeang","year":"1990","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/JVI.75.5.2161-2173.2001","article-title":"CREB\/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein","volume":"75","author":"Kibler","year":"2001","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2001-12-0372","article-title":"Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis","volume":"100","author":"Arnulf","year":"2002","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275.013k43_275_281","article-title":"Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples","volume":"96","author":"Nicot","year":"2000","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/JVI.72.2.1165-1170.1998","article-title":"Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein","volume":"72","author":"Choi","year":"1998","journal-title":"J. Virol."},{"key":"ref_46","first-page":"14","article-title":"HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16Ink4a and counteracts its inhibitory activity to CDK4","volume":"11","author":"Suzuki","year":"1997","journal-title":"Leukemia"},{"key":"ref_47","first-page":"4","article-title":"Centrosome and retroviruses: the dangerous liaisons","volume":"14","author":"Afonso","year":"2007","journal-title":"Retrovirology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.18632\/oncotarget.179","article-title":"Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?","volume":"1","author":"Jeang","year":"2010","journal-title":"Oncotarget"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1128\/jvi.71.6.4445-4451.1997","article-title":"Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways","volume":"71","author":"Matsumoto","year":"1997","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1128\/jvi.66.7.4570-4575.1992","article-title":"Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture","volume":"66","author":"Grassmann","year":"1992","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nm1389","article-title":"Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2009-10-246959","article-title":"Adult T-cell leukemia\/lymphoma development in HTLV-1-infected humanized SCID mice","volume":"115","author":"Banerjee","year":"2010","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065","article-title":"Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia","volume":"88","author":"Tamiya","year":"1996","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/blood.V97.4.987","article-title":"Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia","volume":"97","author":"Furukawa","year":"2001","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1128\/JVI.76.18.9389-9397.2002","article-title":"5\u2019-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo","volume":"76","author":"Koiwa","year":"2002","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells","volume":"109","author":"Takeda","year":"2004","journal-title":"Int. J. Cancer."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"43620","DOI":"10.1074\/jbc.M307275200","article-title":"The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity","volume":"278","author":"Basbous","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Taylor, J.M., Ghorbel, S., and Nicot, C. (2009). Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30. BMC Genomics, 10.","DOI":"10.1186\/1471-2164-10-311"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1742-4690-4-49","article-title":"Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival","volume":"4","author":"Datta","year":"2007","journal-title":"Retrovirology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1128\/JVI.00091-08","article-title":"Human T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycle","volume":"82","author":"Liu","year":"2008","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1745","article-title":"Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells","volume":"14","author":"Jones","year":"2008","journal-title":"Nat. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1084\/jem.20101095","article-title":"Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia","volume":"207","author":"Hasegawa","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1128\/JVI.02564-08","article-title":"Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon","volume":"83","author":"Kinpara","year":"2009","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cbi.2010.06.005","article-title":"HTLV-1 Tax: Linking transformation, DNA damage and apoptotic T-cell death","volume":"188","author":"Chlichlia","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.emboj.7601054","article-title":"Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence","volume":"25","author":"Kuo","year":"2006","journal-title":"EMBO J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1074-7613(00)00065-0","article-title":"Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I","volume":"13","author":"Hanon","year":"2000","journal-title":"Immunity"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1073\/pnas.0608832104","article-title":"In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection","volume":"104","author":"Asquith","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Satou, Y., Yasunaga, J., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P.L., Ohkura, N., Yamaguchi, T., Ono, M., Sakaguchi, S., and Matsuoka, M. (2011). HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation in vivo. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1001274"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","article-title":"New therapeutic approaches for adult T-cell leukaemia","volume":"5","author":"Bazarbachi","year":"2004","journal-title":"Lancet Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-1702(01)00286-6","article-title":"Treatment of adult T-cell leukaemia\/lymphoma: current strategy and future perspectives","volume":"78","author":"Bazarbachi","year":"2001","journal-title":"Virus Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":", Bazarbachi, A. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa","volume":"332","author":"Hermine","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1097\/00042560-199600001-00028","article-title":"Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia\/lymphoma patients","volume":"13","author":"Bazarbachi","year":"1996","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428190109057927","article-title":"The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia\/lymphoma","volume":"40","author":"White","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","article-title":"Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients","volume":"113","author":"Matutes","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.thj.6200195","article-title":"A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma","volume":"3","author":"Hermine","year":"2002","journal-title":"Hematol. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10428190601071717","article-title":"Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran","volume":"48","author":"Kchour","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ratner, L., Harrington, W., Feng, X., Grant, C., Jacobson, S., Noy, A., Sparano, J., Lee, J., Ambinder, R., Campbell, N., Lairmore, M., and AIDS Malignancy Consortium (2009). Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004420"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1080\/1042819021000039983","article-title":"Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide","volume":"43","author":"Besson","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12185-010-0717-3","article-title":"Interferon-\u03b1 and zidovudine for relapsed\/refractory adult T cell leukemia\/lymphoma: Case reports of Japanese patients","volume":"92","author":"Ishitsuka","year":"2010","journal-title":"Int. J. Hematol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","article-title":"The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial","volume":"317","author":"Fischl","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","article-title":"Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures","volume":"81","author":"Goodbourn","year":"2000","journal-title":"J. Gen. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1182\/blood-2009-06-224741","article-title":"Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells","volume":"115","author":"Colisson","year":"2010","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0145-2126(90)90172-6","article-title":"Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits","volume":"14","author":"Isono","year":"1990","journal-title":"Leuk. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1099\/0022-1317-78-5-1007","article-title":"AZT inhibits the transmission of human T cell leukaemia\/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro","volume":"5","author":"Macchi","year":"1997","journal-title":"J. Gen. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2010-02-270751","article-title":"Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors","volume":"116","author":"Afonso","year":"2010","journal-title":"Blood"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"13389","DOI":"10.1128\/JVI.77.24.13389-13395.2003","article-title":"Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts","volume":"77","author":"Feng","year":"2003","journal-title":"J. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/viro.1996.0101","article-title":"High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis","volume":"217","author":"Daenke","year":"1996","journal-title":"Virology"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Oliere, S., Hernandez, E., Lezin, A., Arguello, M., Douville, R., Nguyen, T.L., Olindo, S., Panelatti, G., Kazanji, M., Wilkinson, P., Sekaly, R.P., Cesaire, R., and Hiscott, J. (2010). HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1). PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001177"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0609.1993.tb00632.x","article-title":"Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562","volume":"51","author":"Tosi","year":"1993","journal-title":"Eur. J. Haematol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/sj.leu.2401742","article-title":"Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia\/lymphoma","volume":"14","author":"Bazarbachi","year":"2000","journal-title":"Leukemia"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","article-title":"Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence","volume":"108","author":"Datta","year":"2006","journal-title":"Blood"},{"key":"ref_98","unstructured":"El Hajj, H., Hermine, O., de Th\u00e9, H., and Bazarbachi, A. (2010). American University of Beirut, Beirut, Lebanon; H\u00f4pital Necker-Enfants Malades, Paris, France; INSERM, Universit\u00e9 Paris Diderot U 7212, Unit\u00e9 944, Paris, France. The combination AZT\/IFN is not effective in Tax-transgenic murine ATL, Unpublished work."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1158\/1078-0432.CCR-09-0209","article-title":"Therapy-induced PML\/RARA proteolysis and acute promyelocytic leukemia cure","volume":"15","author":"Nasr","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm.1891","article-title":"Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation","volume":"14","author":"Nasr","year":"2008","journal-title":"Nat. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V93.1.278","article-title":"Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells","volume":"93","author":"Bazarbachi","year":"1999","journal-title":"Blood"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1182\/blood.V98.13.3762","article-title":"Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage","volume":"98","author":"Mahieux","year":"2001","journal-title":"Blood"},{"key":"ref_104","first-page":"2849","article-title":"Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation","volume":"96","author":"Nasr","year":"2000","journal-title":"Blood"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.thj.6200374","article-title":"Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"5","author":"Hermine","year":"2004","journal-title":"Hematol. J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3324\/haematol.10703","article-title":"Therapeutic potential of arsenic trioxide with or without interferon-alpha for relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"92","author":"Ishitsuka","year":"2007","journal-title":"Haematologica"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2006.02.003","article-title":"The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus)","volume":"70","author":"Heraud","year":"2006","journal-title":"Antivir. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","article-title":"Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL)","volume":"113","author":"Kchour","year":"2009","journal-title":"Blood"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.onc.1208212","article-title":"Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia\/lymphoma","volume":"24","author":"Nasr","year":"2005","journal-title":"Oncogene"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0952-7915(00)00107-2","article-title":"The immune response to HTLV-I","volume":"4","author":"Bangham","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jmv.20807","article-title":"Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers","volume":"79","author":"Akimoto","year":"2007","journal-title":"J. Med. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","article-title":"Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes","volume":"95","author":"Hanon","year":"2000","journal-title":"Blood"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"A59","DOI":"10.1186\/1742-4690-8-S1-A59","article-title":"Arsenic Trioxyde in the treatment of HTLV1 associated ATLL","volume":"8","author":"Suarez","year":"2011","journal-title":"Retrovirology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/3\/6\/750\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:56:25Z","timestamp":1760219785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/3\/6\/750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,14]]},"references-count":114,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6]]}},"alternative-id":["v3060750"],"URL":"https:\/\/doi.org\/10.3390\/v3060750","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,14]]}}}